BARDA DRIVe EZ-BAA-22-100-SOL-00003
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Health and Human Services (HHS), specifically BARDA DRIVe, has reissued its EZ-BAA as EZ-BAA-22-100-SOL-00003. This Broad Agency Announcement (BAA) seeks innovative solutions across multiple research areas of interest (AOIs) to advance health security. The overall response period for this BAA extends until October 18, 2027.
Scope of Work
This reissued BAA opens several new research areas of interest (AOIs), each with specific details and closing dates to be found in the amendment. These AOIs include:
- AOI #15: ReDIRECT
- AOI #16: Lab at Home
- AOI #17: Digital MCMs
- AOI #18: Host-Directed Therapeutics
- AOI #19: Healing Lungs
- AOI #20: DRIVe Forward
- AOI #21: Vaccines on Demand
- AOI #22: ReBooT
- AOI #23: Host-Based Diagnostics
Contract & Timeline
- Type: Broad Agency Announcement (BAA)
- Set-Aside: None specified
- Overall Response Due: October 18, 2027
- Published: October 18, 2022
Additional Notes
This announcement supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g., BAA-20-100-SOL-0002). Proposers should reference the attached announcement and applicable amendments for specific details on each AOI, including individual closing dates. Further information is available at https://drive.hhs.gov/.